A Phase I/II Clinical Study of SK&F-105517-D in Japanese Patients With Chronic Heart Failure

NCT00742508 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure, Congestive

Interventions

DRUG: SK&F-105517-D 10 mg capsule
DRUG: Carvedilol-immediate release (IR) 2.5 mg tablet
DRUG: SK&F-105517-D 20 mg capsule
DRUG: SK&F-105517-D 40 mg capsule
DRUG: Carvedilol-IR 10 mg tablet

Sponsor

GlaxoSmithKline